Takeda Canada, a subsidiary of Takeda Pharmaceutical Co. Ltd. (TAK), Thursday announced that it has finalized a Letter of Intent with pan-Canadian Pharmaceutical Alliance or pCPA for Livtencity, which is used to treat patients suffering from post-transplant cytomegalovirus infection.
Feb. 29 is rare disease day - WesternWheel.ca westernwheel.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from westernwheel.ca Daily Mail and Mail on Sunday newspapers.
Feb. 29 is rare disease day - StAlbertGazette.com stalbertgazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stalbertgazette.com Daily Mail and Mail on Sunday newspapers.
Feb. 29 is rare disease day fitzhugh.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fitzhugh.ca Daily Mail and Mail on Sunday newspapers.